Summary
Updated Aug 31, 2026
Brian Russell Wong is PRESIDENT AND CEO of RAPT Therapeutics, Inc. (RAPT). 2 SEC Form 4 filings on record going back to 2024, most recently on 5 March 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Brian Russell Wong has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Brian Russell Wong's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mark A. Goldsmith - $54.82M of RVMD open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $54.63M of WVE open-market activity in the last 12 months
- Neil Kumar - $53.07M of BBIO open-market activity in the last 12 months
- Randal J. Kirk - $52.87M of PGEN open-market activity in the last 12 months
- ORBIMED ADVISORS LLC - $51.68M of ELVN open-market activity in the last 12 months
- Casdin Partners Master Fund, L.P. - $49.54M of BLFS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Brian Russell Wong?
Brian Russell Wong is a corporate insider, tracked as PRESIDENT AND CEO of RAPT Therapeutics, Inc. (RAPT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Brian Russell Wong last file a Form 4?
The most recent primary Form 4 on record is dated 5 March 2026, one of 2 filings going back to 2024.
Where can I see all of Brian Russell Wong's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Brian Russell Wong and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
